Towards the comprehension of heterogeneity of clinical manifestations related with antiphospholipid antibodies;Hacia la comprensión de la heterogeneidad de las manifestaciones clínicas asociadas a los anticuerpos antifosfolípidos

Medicina Clinica

Volumn 125, Issue 5, 2005, Pages 187-189

  Alijotas Reig, Jaume ^a,b,c  

^a Hospital Universitari   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Universitat Autònoma de Barcelona ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 12; GLYCOPROTEIN IB; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; THROMBOMODULIN;

ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; AUTOIMMUNITY; CLINICAL FEATURE; HUMAN; IMMUNOGENICITY; OBSTETRICS; REVIEW; VENOUS THROMBOEMBOLISM;

EID: 23444440318     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13077146     Document Type: Review

References (43)

1. Hughes GRV. Thrombosis, abortion, cerebral disease and lupus anticoagulant. Br Med J. 1983;287:1088-9.
2. Cervera R, Piette JC, Font J, Khamastha MA, Shoenfeld Y, Camps M, et al. Antiphospholipid syndrome: clinical and immunological manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum. 2002;46:1019-27.
3. Galli M, Barbui T. Antiphospholipid syndrome: definition and treatment. Semin Thromb Haemost. 2003;29:195-203.
4. Rand JH. Molecular pathogenesis of the antiphospholipid syndrome. Circul Res. 2002;90:29-37.
5. Meroni PL, Riboldi P. Pathogenic mechanisms mediating antiphospholipid síndrome. Curr Opoin Rheumatol. 2001;113:37-82.
6. Orts JA, Zuñiga A, Orera M. Actualización del síndrome antifosfolípido. Med Clin (Barc). 2003;121:459-71.
7. Sing AK. Immunopathogenesis of the antiphospholipid syndrome: an update. Curr Opin Nephrol Hypertens. 2001;10:355-8.
8. Wilson AW, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette J, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum. 1999;42:1309-11.
9. Wilson WA, Gharavi AE, Piette JC. International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium. Lupus. 2001;10:457-60.
10. Balasch J, Reverter JC, Creus M, Tassies D, Fabregues F, Carmona F, et al. Human reproductive failure is not a clinical feature associated with B2glicoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients. Human Reprod. 1999;14:1956-9.
11. Shoenfeld Y, Blank M. Autoantibodies associated with reproductive failure. Lupus. 2004;13:643-8.
12. Meroni PL, Di Simone N, Testoni C, D'Asta M, Acaia B, Caruso A. Antiphospholipid antibodies as cause of pregnancy loss. Lupus. 2004;13:649-52.
13. Blank M, Shoenfeld Y. Antiphosphatidylserine antibodies and reproductive failure. Lupus. 2004;13:661-5.
14. McIntyre JA, Wagenknecht DR, Sugi T. Phospholipid binding plasma proteins required for antiphospholipid antibody detection-an overview. AmJ Reprod Immunol. 1997;37:101-10.
15. Matsubayhasi H, Sugi T, Arai T, Kondo A, Suzuki T, Izumi S, et al. Different antiphospholipid antibodies specificities are found in association with early repeated pregnancy loss versus recurrent IVF-failure patients. Am J Reprod Immunol. 2001;46:323-9.
16. Rote NS, Stetzer BP. Autoimmune disease as a cause of reproductive failure. Clin Lab Med. 2003;265-93.
17. Levy R, Nelson DM. To be or not to be, that is the question. Apoptosis in human trophoblast. Placenta. 2000;21:1-13.
18. Di Simoni N, Meroni PL, Papa N, Raschi E, Caliandro D, De Caro CS, et al. Antiphospholipid antibodies affect trophoblast gonadotrophin secretion and invasiveness by binding directly and through adhered beta-2glicoprotein I. Arthritis Rheum. 2000;43:140-50.
19. Rand JH, Wu XX, Guller, Gil J, Guha A, Scher J, et al. Reduction of annexin-V on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol. 1994;171:1566-72.
20. McIntyre JA. Immune recognition at the maternal-fetal interface: overview. Am J Reprod Immunol. 1992;28:127-31.
21. Vogt E, Rote NS. A model for the antiphospholipid antibody syndrome: monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice. Am J Obstet Gynecol. 1996;174:700-7.
22. Sthoeger ZM, Mozes E, Tartakovsky B. Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Natl Acad Sci USA. 1993;90:6464-7.
23. Rote NS, Vogt E, De Vere G, Obringer AR, Nag AK. The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome. Am J Reprod Immunol. 1998;39:125-36.
24. Han X, Fiehler R, Broze GJ. Characterization of the protein Z-dependent protease inhibitor. Blood. 2000;96:3049-55.
25. Gris JC, Amadio C, Mercier E. Anti-protein Z antibodies in women with pathologic pregnancies. Blood. 2003;15:4850-2.
26. La Rosa L, Covini G, Galperin C, Catelli L, Del Papa N, Reina G, et al. Anti-mitochondrial M5 type antibody represents one of serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-B2glicoprotein I antibodies. Clin Exp Immunol. 1998;112:144-51.
27. Greer IA. Endothelial cell microparticles and antiphospholipid syndrome: pathologic explanations and diagnostic opportunities. Thromb Haemomost. 2004;91:636-8.
28. Gharavi AE, Pierangeli SS, Espinola RG, Liu X, Colden-Stanfield M, Harris EN. Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis Rheum. 2002;46:545-52.
29. Pierangeli SS, Harris EN. Antiphospholipid antibodies in an in vivo thrombosis model in mice. Lupus. 1994;3:247-51.
30. Atsumi T, Khamastha MA, Amengual O, Hughes GR. Up-regulated tissue factor expression in antiphospholipid syndrome. Thromb Haemost. 1997;77:222-3.
31. Nakamura N, Ban T, Yamaji K, Yoneda Y, Wada Y. Localization of the apoptosis-inducing activity of lupus anticoagulant in an anexxin V-binding antibody subset. J Clin Invest. 1998;101:1951-9.
32. Dignat-George F, Camoin-Jou L, Sabatier F, Arnaoux D, Anfosso F, Veit V, et al. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost. 2004;91:667-73.
33. Bevers EM, Comfurius P, Dekkers DW, Zwaal RFA, Vuist VMJ, Smeets EF. Trnasmembrane phospholipid distribution in blood cells: control mechanism and pathophysiological significance. J Biol Chem. 1998;379: 973-86.
34. Messri M, Altieri DC. Endothelial cell activation by leucocyte microparticles. J Immunol. 1998;161:4382-7.
35. Combes B, Simon AC, Grau GE, Arnoux D, Camoin L, Sabatier F, et al. in vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus acticoagulant. J Clin Invest. 1999;104:93-102.
36. Galli M, Grassi I, Barbui T. Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and haemolytic uremic syndrome. Thromb Haemost. 1996;75:427-31.
37. Galli M. Which antiphospholipid antibodies should be measured in the antiphospholipid syndrome? Haemostasis. 2000;30 Suppl 2:57-62.
38. Ames PR, Pyke S, Iannaccone L. Antiphospholipid antibodies, haemostatis variables and thrombosis: a survey of 144 patients. Thromb Haemost. 1995;73:768-73.
39. Beutler B, Bazzoni F. TNF apoptosis and autoimmunity a common thread? Blood Cells Mol Dis. 1998;24:216-30.
40. George J, Blank M, Levy Y, Meroni P, Damianovich M, Tincani A, et al. Differential effects of anti-beta2-glycoprotein 1 antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome antiphospholipid syndrome. Circulation. 1998;97:900-6.
41. Laude I, Rongieres-Bertrand C, Boyer-Neumann C, Wolf M, Mairov-Hugel B, Freyssenet JM, et al. Circulating procoagulante microparticles in women with unexplained pregnancy loss: a new insight. Thromb Haemost. 2001;85:18-21.
42. Bretelle F, Sabatier F, Desprez D, Camoin L, Grunebaum L, Combes B, et al. Circulating microparticles: a new marker of procoagulante state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Throm Haemost. 2003;89:486-92.
43. Carp H, Dardik R, Lubetsky A, Salomon O, Eskaraev R, Rosenthal E, et al. Prevalence of procoagulant microparticles in women with recurrent miscarriage: a case-controlled study. Hum Reprod. 2004;19:191-5.